MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Enzyme For Treatment Of Diabetic Kidney Disease

Back to diabetes watch blog Blogs list Cancer blog  


Subscribe To Diabetes Watch Blog RSS Feed  RSS content feed What is RSS feed?

Enzyme For Treatment Of Diabetic Kidney Disease

Enzyme For Treatment Of Diabetic Kidney Disease
Northwestern University Feinberg School of Medicine scientists have observed that an enzyme called ACE2 may hold the potential to treat diabetic kidney disease, the most common form of kidney disease.

In the laboratory, scientists led by Daniel Batlle, professor of medicine in the Feinberg School, chief of the nephrology/high blood pressure division and staff nephrologist at Northwestern Memorial Hospital, have found low levels of the ACE2 enzyme in the glomeruli of the kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease from developing, Batlle said.

The experiments appear in a report by Ye et. al in the recent issue of the Journal of the American Society of Nephrology.

Diabetes, which affects 230 million people worldwide and 21 million in the United States, is the leading cause of kidney failure. About one-third of patients with diabetes will go on to develop kidney disease. In diabetes, the small blood vessels in the kidneys are injured and the kidneys cannot clean the blood properly. In 2002, a total of 153,000 people in the U.S. with kidney failure due to diabetes were living on chronic dialysis or with a kidney transplant.

ACE inhibitors are currently used to treat kidney disease, said Batlle, the Earle, del Greco, and Levin Professor of Nephrology/Hypertension. "An eventual ACE2 treatment, perhaps combined with ACE inhibitors could be doubly effective," he said.

"This is a new frontier," said Batlle. "Targeting the ACE2 enzyme may be important, much in the same way as the introduction of ACE inhibitors two decades ago to treat hypertension and slow the progression of kidney disease."

In an editorial that accompanies the publication by Ye et al., Dr. Julie Ingelfinger writes, "The most important aspect of the Ye et al. report is that the work assessed the effect of an ACE2 antagonist, with or without an angiotensin receptor blocker. The ACE2 increased urinary albumin excretion in diabetic animals, but not in control animals. What of ACE2 and the development of therapies? In their article, Ye et al. suggest that ACE2 may regulate the levels of Ang- II within the glomulerulus by degrading it to Ang 1-7, a suggestion supported by the known actions of the enzyme. Such actions provide a rationale for embarking on strategies that might increase ACE2 in diabetes."


Posted by: JoAnn    Source




Did you know?
Northwestern University Feinberg School of Medicine scientists have observed that an enzyme called ACE2 may hold the potential to treat diabetic kidney disease, the most common form of kidney disease. In the laboratory, scientists led by Daniel Batlle, professor of medicine in the Feinberg School, chief of the nephrology/high blood pressure division and staff nephrologist at Northwestern Memorial Hospital, have found low levels of the ACE2 enzyme in the glomeruli of the kidneys of diabetic mice. When ACE2 was further decreased with an inhibitor drug, kidney disease worsened. Studies are now needed using compounds that increase the level of ACE2 in the kidneys of diabetic mice to see if it reverses or prevents kidney disease from developing, Batlle said.

Medicineworld.org: Enzyme For Treatment Of Diabetic Kidney Disease

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.